Bone marrow clearance of eosinophils, however, has not been achieved as often; however, it did not correspond to a clinical response (blood count, signs, and symptoms), and, therefore, its value is usually questionable
Bone marrow clearance of eosinophils, however, has not been achieved as often; however, it did not correspond to a clinical response (blood count, signs, and symptoms), and, therefore, its value is usually questionable. while on maintenance), and 6 were rechallenged with alemtuzumab. Five (83%) achieved second CHR after a median of 3.5 weeks, for a…